These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 39127942)

  • 1. Reprint of: Self-identified prescriber tendencies in sodium-glucose cotransporter-2 inhibitor outpatient prescribing.
    Thompson K; Bowers BL; Evans AM
    J Am Pharm Assoc (2003); 2024; 64(4S):102177. PubMed ID: 39127942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-identified prescriber tendencies in sodium-glucose cotransporter-2 inhibitor outpatient prescribing.
    Thompson K; Bowers BL; Evans AM
    J Am Pharm Assoc (2003); 2024; 64(3):102068. PubMed ID: 38492740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacist impact on evidence-based prescribing of diabetes medications in patients with clinical atherosclerotic cardiovascular disease.
    Trueman C; Shin E; Donovan A; McAdam-Marx C; Coan C
    J Manag Care Spec Pharm; 2023 Dec; 29(12):1275-1283. PubMed ID: 38058135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the implementation of pharmacist prescribing: Challenges and pathways for ambulatory practice.
    Milani GJ; Damasceno LT; Tiguman GMB; Aguiar PM
    Res Social Adm Pharm; 2024 Sep; 20(9):870-879. PubMed ID: 38762366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of a high-prescribing state's 2016 outpatient antibiotic prescriptions: Implications for outpatient antimicrobial stewardship interventions.
    Staub MB; Ouedraogo Y; Evans CD; Katz SE; Talley PP; Kainer MA; Nelson GE
    Infect Control Hosp Epidemiol; 2020 Feb; 41(2):135-142. PubMed ID: 31755401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of prescriber responses to pharmacist recommendations communicated by fax in a medication therapy management program (MTMP).
    Perera PN; Guy MC; Sweaney AM; Boesen KP
    J Manag Care Pharm; 2011 Jun; 17(5):345-54. PubMed ID: 21657804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescribing sodium-glucose co-transporter-2 inhibitors for type 2 diabetes in primary care: influence of renal function and heart failure diagnosis.
    Hinton W; Feher MD; Munro N; Joy M; de Lusignan S
    Cardiovasc Diabetol; 2021 Jun; 20(1):130. PubMed ID: 34183018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of Knowledge and Perception of Sodium-Glucose Co-transporter 2 (SGLT-2) Inhibitors Prescription among Physicians in Saudi Arabia.
    Somaili M; Oraibia O; Darraj M; Hassan A; Moafa E; Kulaybi A; Shubayli S; Moafa R; Mghfori G; Jaafari A; Somily M
    Curr Diabetes Rev; 2024; 20(4):e060723218471. PubMed ID: 37415371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescribing Trends of the Sodium-Glucose Cotransporter-2 Inhibitors Among Different Physician Specialties in Canada (2015-2021).
    Alkabbani W; Gamble JM
    Can J Diabetes; 2023 Mar; 47(2):153-161. PubMed ID: 36481264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescriber acceptance rate of pharmacists' recommendations.
    Doellner JF; Dettloff RW; DeVuyst-Miller S; Wenstrom KL
    J Am Pharm Assoc (2003); 2017; 57(3S):S197-S202. PubMed ID: 28408169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-medical prescribing versus medical prescribing for acute and chronic disease management in primary and secondary care.
    Weeks G; George J; Maclure K; Stewart D
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD011227. PubMed ID: 27873322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrating patient-centric indications into the prescribing process: Experience at a tertiary academic medical center.
    Ho J; Wrzesniewski CE; Hasson NK
    Am J Health Syst Pharm; 2020 May; 77(Supplement_2):S26-S33. PubMed ID: 32426831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacist prescribing in Northern Ireland: a quantitative assessment.
    McCann L; Haughey S; Parsons C; Lloyd F; Crealey G; Gormley GJ; Hughes CM
    Int J Clin Pharm; 2011 Oct; 33(5):824-31. PubMed ID: 21830075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of a clinical pharmacist on provider prescribing patterns in a primary care clinic.
    Wei ET; Gregory P; Halpern DJ; Felton M; Goldstein BA; Yeatts J; Shah K; Smith BH
    J Am Pharm Assoc (2003); 2022; 62(1):209-213.e1. PubMed ID: 34756524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying opioid prescribing patterns for high-volume prescribers via cluster analysis.
    Nataraj N; Zhang K; Guy GP; Losby JL
    Drug Alcohol Depend; 2019 Apr; 197():250-254. PubMed ID: 30875645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reprint of: Implementation and perception of outpatient pharmacists prescribing hormonal contraceptives in North Carolina.
    Martinez JT; Trotta K; Honeycutt JP; Herring C
    J Am Pharm Assoc (2003); 2024; 64(4S):102172. PubMed ID: 39127934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of pharmacist intervention on physician prescribing in patients with chronic schizophrenia: a descriptive pre/post study.
    Hashimoto Y; Tensho M
    BMC Health Serv Res; 2016 Apr; 16():150. PubMed ID: 27117589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of embedded versus remote pharmacist versus remote student pharmacist outreach on statin prescribing.
    Hayes M; Gregory P; Smith B; Champagne B; Patel A; Alvarado H; Roberson C; Yang C; Lee HJ; Erkanli A
    J Am Pharm Assoc (2003); 2024; 64(4S):102127. PubMed ID: 38796162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Community pharmacists' awareness, identification, and management of prescribing cascades: A cross-sectional survey.
    Dalton K; Callaghan R; O'Sullivan N; McCarthy L
    Res Social Adm Pharm; 2024 Jun; 20(6):102-112. PubMed ID: 38768989
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.